Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Associate Professor Belinda Miller is a consultant physician in respiratory and sleep disorders, with over 25 years’ experience. She has a PhD in respiratory physiology during sleep, and ongoing research interests in sleep, ventilatory failure and COPD. She is medical lead for oxygen therapy at Alfred Health, and a clinical
Dr Annika Smith is a Fellow of the Australasian College of Dermatologists and Consultant Dermatologist in public and private settings in Sydney. Annika undertook training at the prestigious St John’s Institute of Dermatology London, followed by further sub-specialty training in New York. Annika has a special interest in complex medical
Dr Annette Tognela is a senior medical oncologist and Director of the Macarthur Cancer Therapy Centre, Campbelltown. She specialises in gastrointestinal, lung and brain cancers and also practices at GenesisCare, Campbelltown. Dr Tognela is a Conjoint Senior Lecturer at the Western Sydney University and is an investigator on gastrointestinal clinical
Associate Professor Anneke van der Walt is a Neurologist specialising in the management of Multiple Sclerosis and Neuro-ophthalmology. She is appointed as the Head of MS and Neuroimmunology Unit and Neuro-ophthalmology Service at Alfred Health, Melbourne. Her research group is based in the Department of Neuroscience, Central Clinical School, Monash
Anna is a staff specialist haematologist at the Royal Hobart Hospital, Head of Clinical Haematology and the Tasmanian Statewide Bone Marrow Transplant service. She trained in Sydney, Canberra and France before returning to Hobart in 2011. Her main research interest is haematological malignancy, particularly lymphoma and supportive care. Anna is
Associate Professor Andrew Weickhardt is a medical oncologist at the Olivia Newton-John Cancer and WellnessCentre in Melbourne. He has an interest in using immunotherapy and personalised treatments for patients with genitourinary cancer. He is actively involved in translational research investigating biomarkers of response andresistance to these treatments, and is involved
A/Prof Andrew Östör is a Consultant Rheumatologist at Cabrini Medical Centre and Researcher at Emeritus Research, Melbourne, Australia and Honorary Consultant Rheumatologist at Addenbrooke’s Hospital, Cambridge, UK. He was formally the Director of the Rheumatology Clinical Research Unit at Addenbrooke’s Hospital, a post that he held for 10 years. His
Andrew was born and schooled in Melbourne and studied medicine at Oxford and Cambridge. He has more than 110,000 citations, and an H-index of 141. He served as Editor-in-Chief of the International Journal of Cardiology from 1999 to 2016. Andrew published the first randomised trial of exercise training for CHF.
Dr Andrew Buckle is a gastroenterologist and molecular biologist with the Peter MacCallum Cancer Centreand Royal Melbourne Hospital. He is also an Honorary Fellow with the Department of Medicine at theUniversity of Melbourne. Andrew’s clinical interest is the diagnosis and management of people at high risk ofgastrointestinal cancers and gastrointestinal
Dr Alexander Davis is a Medical Oncologist at Royal North Shore Hospital, North Shore Private Hospital and Genesis Care North Shore. He is currently undertaking a PhD in KRAS mutant lung cancers at the University of Sydney.
Dapibus donec magna nunc habitant amet in at. Dolor nisl lobortis sit nunc ultrices mi elit amet.
